114684-69-4

Basic information

• Product Name: METHYL CBZ-AMINO(DIETHOXYPHOSPHORYL)ACETATE
• Synonyms: METHYL CBZ-AMINO(DIETHOXYPHOSPHORYL)ACETATE;Benzyloxycarbonylamino-(diethoxy-phosphoryl)-acetic acid methyl ester;methyl 2-(benzyloxycarbonylamino)-2-(diethoxyphosphoryl)acetate;Acetic acid, 2-(diethoxyphosphinyl)-2-[[(phenylMethoxy)carbonyl]aMino]-, Methyl ester;-2-(diethoxyphosphoryl)
• CAS NO: 114684-69-4
• Molecular Formula: C₁₅H₂₂NO₇P
• Molecular Weight: 359.31
• Mol File: 114684-69-4.mol

Chemical Properties

• Melting Point: 79-81℃
• Boiling Point: 500.6°Cat760mmHg
• Flash Point: 256.6°C
• Appearance: /
• Density: 1.235g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.501
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 9.59±0.46(Predicted)
• CAS DataBase Reference: METHYL CBZ-AMINO(DIETHOXYPHOSPHORYL)ACETATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL CBZ-AMINO(DIETHOXYPHOSPHORYL)ACETATE(114684-69-4)
• EPA Substance Registry System: METHYL CBZ-AMINO(DIETHOXYPHOSPHORYL)ACETATE(114684-69-4)

Safety Data

• Hazardous Substances Data: 114684-69-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
METHYL CBZ-AMINO(DIETHOXYPHOSPHORYL)ACETATE is used as an intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
It is utilized as an intermediate in the production of agrochemicals, aiding in the creation of compounds for agricultural applications such as pesticides and herbicides.
Used in Chemical Research and Development:
METHYL CBZ-AMINO(DIETHOXYPHOSPHORYL)ACETATE is used as a reagent for organic synthesis and molecular modification, facilitating advancements in chemical research and the discovery of novel compounds.
Used in Medicine as a Prodrug:
It has potential applications in medicine as a prodrug, which can be metabolized in the body to yield active pharmaceutical ingredients, enhancing drug efficacy and targeting specific conditions.

InChI:InChI=1/C15H22NO7P/c1-4-22-24(19,23-5-2)13(14(17)20-3)16-15(18)21-11-12-9-7-6-8-10-12/h6-10,13H,4-5,11H2,1-3H3,(H,16,18)

Upstream product

• 127357-37-3 methyl 2-(benzyloxycarbonylamino)-2-methoxyacetate 
• 120341-31-3 tert-butyldimethylsilyloxydiethyl phosphonic ester 
• 122-52-1 triethyl phosphite 
• 13716-45-5 diethyl trimethylsilyl phosphite 
• 64356-76-9 N-benzyloxycarbonyl α-chloro glycine methyl ester 
• 621-84-1 O-benzyl carbamate 
• 79002-45-2 N-benzyloxycarbonyl-glycine 
• 78-40-0 triethyl phosphate 
• 127357-38-4 N-(benzyloxycarbonyl)-α-hydroxy-glycine methyl ester 

Downstream Products

• 116835-85-9 Cbz-ΔTyr(Ac)-OMe 
• 849340-23-4 (Z)-methyl 2-benzyloxycarbonylamino-4-phenylbut-2-enoate 
• 116835-90-6 (Z)-Cbz-ΔTyr-OH 
• 116835-87-1 (Z)-Cbz-ΔTyr(Me)-OH 
• 116835-89-3 (Z)-Cbz-ΔTyr(Ac)-OH 
• 477584-90-0 methyl 2-(((benzyloxy)carbonyl)amino)-2-(dihydro-2H-pyran-4(3H)-ylidene)acetate 
• 684283-02-1 methyl 2-(benzyloxycarbonylamino)-2-(1,4-dioxaspiro[4.5]decan-8-ylidene)acetate 
• 871675-57-9 (Z)-methyl 2-benzyloxycarbonylaminohepta-2,6-dienoate 
• 220854-85-3 (Z)-2-Benzyloxycarbonylamino-3-[6-((Z)-2-benzyloxycarbonylamino-2-methoxycarbonyl-vinyl)-pyridin-2-yl]-acrylic acid methyl ester 
• 220854-80-8 (Z)-2-Benzyloxycarbonylamino-3-(6-methyl-pyridin-2-yl)-acrylic acid methyl ester 
• 220854-79-5 (Z)-2-Benzyloxycarbonylamino-3-pyridin-2-yl-acrylic acid methyl ester 
• 173327-94-1 methyl (4S,2E)-2-benzyloxycarbonylamino-4,5-isopropylidenedioxy-2-pentanoate 
• 132970-32-2 methyl (4S,2Z)-2-benzyloxycarbonylamino-4,5-isopropylidenedioxy-2-pentanoate 
• 116835-82-6 methyl (Z)-2-carbobenzoxyamino-3-(4-methoxyphenyl)acrylate 

Relevant articles and documents

Total Synthesis and Structure-Activity Relationships Study of Odilorhabdins, a New Class of Peptides Showing Potent Antibacterial Activity

The spread of antibiotic-resistant pathogens is a growing concern, and new families of antibacterials are desperately needed. Odilorhabdins are a new class of antibacterial compounds that bind to the bacterial ribosome and kill bacteria through inhibition

NOVEL PEPTIDE DERIVATIVES AND USES THEREOF

The invention provides for novel peptide derivatives and compositions comprising the same. The invention further provides methods of treatment comprising administering novel peptide derivatives and/or compositions comprising the same.

NOVEL HETEROARYL AND HETEROCYCLE COMPOUNDS, COMPOSITIONS AND METHODS

The invention relates to novel heteroaryl and heterocycle compounds of formula I and pharmaceutical compositions comprising them, uses and methods thereof for inhibiting the activity of PI3K and for treating inflammatory and autoimmune diseases and cancer.

BARETTIN AND DERIVATIVES THEREOF FOR MEDICAL USE, IN PARTICULAR FOR THE TREATMENT OF DISEASES RELATED TO OXIDATIVE STRESS OR INFLAMMATION, AND FOR PRESERVING OR WASHING ORGANS

The present invention relates to compounds of formula(I) herein, which includes barettin and derivatives thereof, or any pharmaceutically acceptable salt thereof for use as a medicament. Further the present invention relates to same compounds for use in t

NOVEL HETEROARYL AND HETEROCYCLE COMPOUNDS, COMPOSITIONS AND METHODS

Provided are novel heteroaryl and heterocycle compounds of formula (I-1), (I-2) or (I-3) and pharmaceutical compositions comprising them, uses and methods thereof for inhibiting the activity of PI3K and for treating inflammatory and autoimmune disorders diseases and cancer.

NOVEL HETEROARYL AND HETEROCYCLE COMPOUNDS, COMPOSITIONS AND METHODS

The invention relates to novel heteroaryl and heterocycle compounds and pharmaceutical compositions comprising them, uses and methods thereof for inhibiting the activity of PI3k and for treating inflammatory and autoimmune disorders diseases and cancer.

NOVEL HETEROARYL AND HETEROCYCLE COMPOUNDS, COMPOSITION AND METHODS THEREOF

Disclosed are novel heteroaryl and heterocycle compounds of formula I-1, I-2 or I-3 and pharmaceutical compositions comprising them, uses and methods thereof for inhibiting the activity of PI3K and for treating inflammatory and autoimmune diseases and cancer.

Efficient synthesis of DOPA analogues in pepticinnamins E via asymmetric catalytic hydrogenation of dehydroamino esters

One practical synthetic procedure with five steps was developed to prepare a series of N-protected-2-(diethoxyphosphoryl)glycinates with good yields, which was treated with aldehydes under mild condition to give different dehydroamino esters with high yields and excellent Z/E selectivity. The subsequently homogeneous enantioselective hydrogenation of the dehydroamino esters affords a series of new DOPA analogues.

Bicyclic heterocycles as cannabinoid receptor modulators

The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the general Formula I: including all prodrugs, pharmaceutically acceptable salts and stereoisomers, R1, R2, R3, R3a, R4, A, B, n, Y and Z are described herein.

Bicyclic heterocycles as cannabinoid receptor modulators

The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds a